Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary central nervous system lymphoma.

L M DeAngelis1

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Current Opinion in Neurology
|February 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas.

Journal of neuro-oncology·2017
Same author

OC-02 - Risk of arterial thromboembolism in patients with breast cancer.

Thrombosis research·2016
Same author

Multimodality imaging of primary CNS lymphoma in immunocompetent patients.

The British journal of radiology·2014
Same author

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.

Leukemia·2011
Same author

Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Leptomeningeal metastases in the MRI era.

Neurology·2010

Chemotherapy is now the recommended first-line treatment for primary central nervous system (CNS) lymphoma, offering superior survival rates compared to radiotherapy alone. Further treatment decisions depend on individual patient factors and response to initial chemotherapy.

Area of Science:

  • Neuro-oncology
  • Hematology
  • Radiation Oncology

Background:

  • Primary central nervous system (CNS) lymphoma is an uncommon yet increasingly diagnosed brain tumor.
  • Advances in treatment have significantly improved patient survival outcomes.

Purpose of the Study:

  • To evaluate the efficacy of chemotherapy as a primary treatment for CNS lymphoma.
  • To determine the role of subsequent cranial radiotherapy based on patient response.

Main Methods:

  • Review of treatment protocols for primary CNS lymphoma.
  • Analysis of survival data comparing chemotherapy alone, radiotherapy alone, and combined modality treatments.
  • Assessment of factors influencing treatment decisions and outcomes.

Main Results:

Related Experiment Videos

  • Chemotherapy alone provides substantial disease-free survival and superior survival rates compared to radiotherapy alone.
  • Combined modality treatment with chemotherapy and cranial radiotherapy has improved survival.
  • Chemotherapy is now considered the preferred first-line treatment approach.

Conclusions:

  • Chemotherapy should be the initial treatment for all primary CNS lymphoma patients.
  • The necessity of subsequent cranial radiotherapy should be individualized based on patient condition, age, and response.
  • Future research focuses on intensified chemotherapy regimens to reduce neurotoxicity.